Dow Down 0.62% Nasdaq Down 1.14%

Celladon Corporation (CLDN)

-NasdaqGM
10.08 0.09(0.88%) Sep 22, 3:59PM EDT
Prev Close:10.17
Open:10.01
Bid:9.00 x 2800
Ask:15.17 x 500
1y Target Est:16.50
Beta:N/A
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:9.80 - 10.10
52wk Range:7.45 - 17.16
Volume:92,440
Avg Vol (3m):162,683
Market Cap:186.82M
P/E (ttm):N/A
EPS (ttm):-7.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDN

Comparison

Symbol% ChgMkt Cap
CLDNDown 0.88%186.82M
ACTCN/A
ABIO27.10M
GSK113.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.76
Quarterly EPS Est (Sep-14) :-0.38
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celladon Corporation, a clinical-stage biotechnology company, focuses on developing treatments for heart failure, diabetes, and neurodegenerative diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback